Wong ET - Search Results

1

Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.

Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J. Lukas RV, et al. Among authors: wong et. J Neurooncol. 2018 Nov;140(2):317-328. doi: 10.1007/s11060-018-2955-9. Epub 2018 Aug 2. J Neurooncol. 2018. PMID: 30073642 Clinical Trial.

2

A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.

Drappatz J, Wong ET, Schiff D, Kesari S, Batchelor TT, Doherty L, Lafrankie DC, Ramakrishna N, Weiss S, Smith ST, Ciampa A, Zimmerman J, Ostrowsky L, David K, Norden A, Barron L, Sceppa C, Black PM, Wen PY. Drappatz J, et al. Among authors: wong et. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):222-7. doi: 10.1016/j.ijrobp.2008.03.046. Epub 2008 May 29. Int J Radiat Oncol Biol Phys. 2009. PMID: 18513880 Clinical Trial.

3

Bevacizumab for recurrent glioblastoma multiforme: a meta-analysis.

Wong ET, Gautam S, Malchow C, Lun M, Pan E, Brem S. Wong ET, et al. J Natl Compr Canc Netw. 2011 Apr;9(4):403-7. doi: 10.6004/jnccn.2011.0037. J Natl Compr Canc Netw. 2011. PMID: 21464145

4

The natural history of extracranial metastasis from glioblastoma multiforme.

Lun M, Lok E, Gautam S, Wu E, Wong ET. Lun M, et al. Among authors: wong et. J Neurooncol. 2011 Nov;105(2):261-73. doi: 10.1007/s11060-011-0575-8. Epub 2011 Apr 22. J Neurooncol. 2011. PMID: 21512826

5

NovoTTF-100A: a new treatment modality for recurrent glioblastoma.

Fonkem E, Wong ET. Fonkem E, et al. Among authors: wong et. Expert Rev Neurother. 2012 Aug;12(8):895-9. doi: 10.1586/ern.12.80. Epub 2012 Jun 19. Expert Rev Neurother. 2012. PMID: 22708931 Review.

6

Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial.

Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, Mahadevan A. Floyd SR, et al. Among authors: wong et. Front Oncol. 2012 Oct 16;2:122. doi: 10.3389/fonc.2012.00122. eCollection 2012. Front Oncol. 2012. PMID: 23087896 Free PMC article.

7

A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.

Butowski N, Wong ET, Mehta MP, Wilson LK. Butowski N, et al. Among authors: wong et. Semin Oncol. 2013 Dec;40(6):S2-4. doi: 10.1053/j.seminoncol.2013.10.002. Epub 2013 Oct 10. Semin Oncol. 2013. PMID: 24331200

8

Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.

Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL. Wong ET, et al. Cancer Med. 2014 Jun;3(3):592-602. doi: 10.1002/cam4.210. Epub 2014 Feb 14. Cancer Med. 2014. PMID: 24574359 Free PMC article.

9

Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma.

Lacouture ME, Davis ME, Elzinga G, Butowski N, Tran D, Villano JL, DiMeglio L, Davies AM, Wong ET. Lacouture ME, et al. Among authors: wong et. Semin Oncol. 2014 Jun;41 Suppl 4:S1-14. doi: 10.1053/j.seminoncol.2014.03.011. Epub 2014 Mar 19. Semin Oncol. 2014. PMID: 24794308 Free article.

10

Response patterns of recurrent glioblastomas treated with tumor-treating fields.

Vymazal J, Wong ET. Vymazal J, et al. Among authors: wong et. Semin Oncol. 2014 Oct;41 Suppl 6:S14-24. doi: 10.1053/j.seminoncol.2014.09.009. Epub 2014 Sep 16. Semin Oncol. 2014. PMID: 25213870 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page